Shionogi & Co., Ltd.
SGIOY · OTC
Bulios Fair Price
$12.69
36.2% upside
Current Price
$9.32
According to Bulios Fair Price, SGIOY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Shionogi & Co., Ltd. is a Japanese pharmaceutical company headquartered in Osaka, founded in 1878. The company specializes in the research, development, manufacturing, and distribution of medicines, focusing on areas such as oncology, infectious diseases, cardiovascular diseases, and neurology. Shionogi is known for its strong focus on innovation and quality in healthcare and is active in clinical research and the development of new therapeutic options. The company is also engaged in the global fight against pandemic diseases, such as COVID-19. Shionogi operates not only in Japan but also internationally, with a strong presence in Asia, Europe, and the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Isao Teshirogi
Employees
6,223
Headquarters
Kita
Upcoming events
Ex-Dividend
Ex-dividend date
Earnings
Upcoming earnings report
Dividend Payment
Payment date